From Casetext: Smarter Legal Research

Astrazeneca Pharm. LP v. Blue Cross Blue Shield Massachusetts

Supreme Court of the United States
Sep 28, 2010
561 U.S. 1055 (2010)

Opinion

No. 09–1069 R46–032.

09-28-2010

ASTRAZENECA PHARMACEUTICALS LP, v. BLUE CROSS BLUE SHIELD OF MASSACHUSETTS, et al.


Opinion

The petition for writ of certiorari in the above-entitled case was dismissed today pursuant to Rule 46 of the Rules of this Court.


Summaries of

Astrazeneca Pharm. LP v. Blue Cross Blue Shield Massachusetts

Supreme Court of the United States
Sep 28, 2010
561 U.S. 1055 (2010)
Case details for

Astrazeneca Pharm. LP v. Blue Cross Blue Shield Massachusetts

Case Details

Full title:ASTRAZENECA PHARMACEUTICALS LP, v. BLUE CROSS BLUE SHIELD OF…

Court:Supreme Court of the United States

Date published: Sep 28, 2010

Citations

561 U.S. 1055 (2010)
561 U.S. 1055
177 L. Ed. 2d 1150

Citing Cases

Commonwealth v. Tap Pharm. Prods., Inc.

See 42 U.S.C. § 1395 l; See In re Pharm. Indus. Average Wholesale Price Litig., 491 F.Supp.2d 20, 33…

State v. Abbott Labs.

Thus, in both contexts, the reporting of inflated AWPs harmed Medicaid, and in both the reporting of accurate…